Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:717-727
Published online before print January 26, 2009, doi: 10.1161/CIRCULATIONAHA.108.815712
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
119/5/717    most recent
CIRCULATIONAHA.108.815712v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Almond, C. S.D.
Right arrow Articles by Singh, T.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Almond, C. S.D.
Right arrow Articles by Singh, T.P.
Related Collections
Right arrow Congestive
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery
Right arrowRelated Article

(Circulation. 2009;119:717-727.)
© 2009 American Heart Association, Inc.


Pediatric Cardiology

Waiting List Mortality Among Children Listed for Heart Transplantation in the United States

Christopher S.D. Almond, MD, MPH*; Ravi R. Thiagarajan, MBBS, MPH*; Gary E. Piercey, BS; Kimberlee Gauvreau, ScD; Elizabeth D. Blume, MD; Heather J. Bastardi, NP; Francis Fynn-Thompson, MD; T.P. Singh, MD, MS

From the Department of Cardiology (C.S.D.A., R.R.T., G.E.P., K.G., E.D.B., H.J.B., T.P.S.), Cardiac Surgery (F.F.T.), and the Pediatric Transplant Center (C.S.D.A., E.D.B., H.J.B., F.F.T., T.P.S.), Children’s Hospital Boston; the Department of Pediatrics, Harvard Medical School; and the Department of Biostatistics (K.G.), Harvard School of Public Health; all in Boston, Mass.

Correspondence to Christopher S.D. Almond, MD, MPH, Department of Cardiology, Children’s Hospital Boston, 300 Longwood Ave, Boston, MA 02115. E-mail christopher.almond{at}childrens.harvard.edu

Received August 21, 2008; accepted November 24, 2008.

Background— Children listed for heart transplantation face the highest waiting list mortality in solid-organ transplantation medicine. We examined waiting list mortality since the pediatric heart allocation system was revised in 1999 to determine whether the revised allocation system is prioritizing patients optimally and to identify specific high-risk populations that may benefit from emerging pediatric cardiac assist devices.

Methods and Results— We conducted a multicenter cohort study using the US Scientific Registry of Transplant Recipients. All children <18 years of age who were listed for a heart transplant between 1999 and 2006 were included. Among 3098 children, the median age was 2 years (interquartile range 0.3 to 12 years), and median weight was 12.3 kg (interquartile range 5 to 38 kg); 1294 (42%) were nonwhite; and 1874 (60%) were listed as status 1A (of whom 30% were ventilated and 18% were on extracorporeal membrane oxygenation). Overall, 533 (17%) died, 1943 (63%) received transplants, and 252 (8%) recovered; 370 (12%) remained listed. Multivariate predictors of waiting list mortality include extracorporeal membrane oxygenation support (hazard ratio [HR] 3.1, 95% confidence interval [CI] 2.4 to 3.9), ventilator support (HR 1.9, 95% CI 1.6 to 2.4), listing status 1A (HR 2.2, 95% CI 1.7 to 2.7), congenital heart disease (HR 2.2, 95% CI 1.8 to 2.6), dialysis support (HR 1.9, 95% CI 1.2 to 3.0), and nonwhite race/ethnicity (HR 1.7, 95% CI 1.4 to 2.0).

Conclusions— US waiting list mortality for pediatric heart transplantation remains unacceptably high in the current era. Specific high-risk subgroups can be identified that may benefit from emerging pediatric cardiac assist technologies. The current pediatric heart-allocation system captures medical urgency poorly. Further research is needed to define the optimal organ-allocation system for pediatric heart transplantation.


 

CLINICAL PERSPECTIVE


Related Article:

Circulation: Clinical Summaries
Circulation 2009 119: 649-651. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Circ Heart FailHome page
D. T. Hsu and G. D. Pearson
Heart Failure in Children: Part II: Diagnosis, Treatment, and Future Directions
Circ Heart Fail, September 1, 2009; 2(5): 490 - 498.
[Full Text] [PDF]